MR [Mindray Medical International] 6-K: (Original Filing)
[Mindray intends to vigorously defend the actions. 2 Mindray Medical International Limited 3 6-K 1 d458772d6k.htm FORM 6-K]
MR [Mindray Medical International] 6-K: Mindray intends to vigorously defend the actions. 2
[Mindray intends to vigorously defend the actions. 2 Mindray Medical International Limited 3 6-K 1 d458772d6k.htm FORM 6-K]
MR [Mindray Medical International] 6-K: (Original Filing)
[Mindray Announces Preliminary 2012 Operating Results and 2013 Net Revenue Guidance STYLE="font-family:Times New Roman" SIZE="2"> SHENZHEN, China, January7, 2013 Mindray Medical International Limited (Mindray, NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced selected preliminary, unaudited results for the fiscal year ended December31, 2012. Thempanyso provided net revenue guidance for]
MR [Mindray Medical International] 6-K: Mindray Announces Preliminary 2012 Operating Results and 2013
[Mindray Announces Preliminary 2012 Operating Results and 2013 Net Revenue Guidance STYLE="font-family:Times New Roman" SIZE="2"> SHENZHEN, China, January7, 2013 Mindray Medical International Limited (Mindray, NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced selected preliminary, unaudited results for the fiscal year ended December31, 2012. Thempanyso provided net revenue guidance for]
MR [Mindray Medical International] 6-K: (Original Filing)
[Mindray intends to vigorously defend the actions. 2 Mindray Medical International Limited 3 FORM 6-K d458772d6k.htm 1 6-K]
MR [Mindray Medical International] 6-K: Mindray intends to vigorously defend the actions. 2
[Mindray intends to vigorously defend the actions. 2 Mindray Medical International Limited 3 FORM 6-K d458772d6k.htm 1 6-K]
MR [Mindray Medical International] 6-K: Mindray Announces Preliminary 2012 Operating Results and 2013
[Mindray Announces Preliminary 2012 Operating Results and 2013 Net Revenue Guidance SHENZHEN, China, January7, 2013 Mindray Medical International Limited (Mindray, NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced selected preliminary, unaudited results for the fiscal year ended December31, 2012. Thempanyso provided net revenue guidance for 2013.]
MR [Mindray Medical International] 6-K: Mindray intends to vigorously defend the actions. 2
[Mindray intends to vigorously defend the actions. 2 Mindray Medical International Limited 3 FORM 6-K d458772d6k.htm 1 6-K]
DHRM [Dehaier Medical Systems] 8-K: (Original Filing)
[Dehaier Medical Announces Management Change Beijing, January XX, 2013- Dehaier Medical Systems Ltd. Mr. Li worked as senior auditor in KPMG Huazhen Beijing for two years with extensive experience in audit schemes and internal control as well as financial management. He is very familiar with US GAAP, China GAAP and the Sarbanes-Oxley Act. He joined in Dehaier in 2010 as] []
DHRM [Dehaier Medical Systems] 8-K: Dehaier Medical Announces Management Change Beijing, January XX,
[Dehaier Medical Announces Management Change Beijing, January XX, 2013- Dehaier Medical Systems Ltd. Mr. Li worked as senior auditor in KPMG Huazhen Beijing for two years with extensive experience in audit schemes and internal control as well as financial management. He is very familiar with US GAAP, China GAAP and the Sarbanes-Oxley Act. He joined in Dehaier in 2010 as] []
